Compare
Enovis vs Medtronic (ENOV vs MDT)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Enovis (ENOV) returned -13.8% and Medtronic (MDT) +12.6%; so far this year the figures are +1.9% and +6.0%.
Medtronic is the larger company by market value, about 82.9 times the size of Enovis.
Revenue grew +3.3% at ENOV and +9.8% at MDT over the last year.
ENOV pays no dividend. MDT yields 2.81%.
Data as of the latest close. Not investment advice.
Relative performance
| ENOV | MDT | |
|---|---|---|
| Price | $27.16 | $101.80 |
| 1-day | -5.10% | -2.90% |
| YTD | +1.95% | +5.98% |
| 1 year | -13.75% | +12.61% |
| 3 years | -39.68% | +43.68% |
| Market cap | $1.6B | $130.2B |
| P/E | — | 25.0 |
| P/S | 0.68 | 3.47 |
| P/B | 1.05 | 2.59 |
| Revenue growth | +3.30% | +9.80% |
| EPS growth | — | +12.10% |
| Gross margin % | 61.3 | 65.0 |
| Net margin % | -22.9 | 13.9 |
| ROE % | -35.3 | 10.4 |
| Debt / equity | 0.84 | 0.56 |
| FCF yield % | 4.4 | 4.7 |
| Dividend yield % | — | 2.81 |
| Beta | 1.04 | 0.14 |
| RSI (14) | 69.3 | 63.8 |
| Technical rating |